The main purpose of any regulation on the manufacture and distribution of medicinal products for human use should be to safeguard public health. However, this objective should be achieved by means which do not hinder the development of the pharmaceutical industry or trade in medicinal products in the Community.
Recital 4, Directive (EU) 2004/27
In forcesince 31 Mar 2004cited 2×
Judgment of the Court (First Chamber) of 15 January 2009. Hecht-Pharma GmbH v Staatliches Gewerbeaufsichtsamt Lüneburg.Decision
Recitals 2, 3, 4 and 7 in the preamble to Directive 2004/27 state that: ‘(2) The Community legislation so far adopted has made a major contribution to the achievement of the objective of the free and safe movement of medicinal products …
15 Jan 2009 · 62007CJ0140
Judgment of the Court (Third Chamber) of 16 July 2015. Abcur AB v Apoteket Farmaci AB and Apoteket AB.Decision
Recital 4 in the preamble to Directive 2004/27 states that ‘the primary purpose of any rules concerning the production and distribution of proprietary medicinal products must be to safeguard public health …’.
16 Jul 2015 · 62013CJ0544